Nephrotic syndrome and interstitial nephritis associated with celecoxib

American Journal of Kidney Diseases

Volumn 40, Issue 5, 2002, Pages 1086-1090

  Alper Jr, Arnold B ^a   Meleg Smith, Suzanne ^a   Krane, N Kevin ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interstitial nephritis; Minimal change disease; Nephrotic syndrome; Nonsteroidal anti inflammatory drugs (NSAIDs), cyclooxygenase (COX) inhibitors, celecoxib

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; FUROSEMIDE; GLIPIZIDE; LISINOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; ELECTROLYTE DISTURBANCE; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OSTEOARTHRITIS;

EID: 0036841780     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.36349     Document Type: Article

References (15)

1. Garella S, Matarese RA: Renal effects of prostaglandins and clinical adverse effects of nonsteroidal antiinflammatory agents. Medicine 63:165-181, 1984
2. Carmichael J, Shankel SW: Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 78:992-1000, 1985
3. Whelton A: Nephrotoxicity of non-steroidal antiinflammatory drugs: Physiologic foundations and clinical implications. Am J Med 106:13S-24S, 1999
4. Brater DC: Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclo-oxygenase-selective inhibition. Am J Med 107:65S-71S, 1999
5. Abraham PA, Keane WF: Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs. Am J Nephrol 4:1-6, 1984
6. Feinfeld A, Olesnicky L, Pirani C, Appel G: Nephrotic syndrome associated with use of nonsteroidal anti-inflammatory drugs: Case report and review of the literature. Nephron 37:174-179, 1984
7. Perazella MA, Eras J: Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 35:937-940, 2000
8. Swan SK, Rudy DW, Lasseter KC, et al: Randomized evaluations of the effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: A randomized, controlled trial. Ann Intern Med 133:1-9, 2000
9. Whelton A, Maurath CJ, Verburg KM, Geis GS: Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am J Ther 7:159-175, 2000
10. Porile J, Bakris G, Garella S: Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: A review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol 30:468-475, 1990
11. Davies NM, McLachlan AJ, Day RO, Williams KM: Clinical pharmacokinetics and pharmacodynamics of celecoxib: A selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 38:225-242, 2000
12. Clive DM, Stroff JS: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310:563-572, 1984
13. Whelton A, Hamilton CW: Nonsteroidal anti-inflammatory drugs: Effects on kidney function. J Clin Pharmacol 31:588-598, 1991
14. Demke D, Zhao S, Arellano F: Nephritis associated with celecoxib. Lancet 358:1726-1727, 2001
15. Rocha J, Fernandez-Alonso J: Acute interstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. Lancet 357:1946-1947, 2001